Vivimed Labs EGM held on 10 Dec 2025
Vivimed Labs held an Extraordinary General Meeting (EGM) on December 10, 2025, to vote on the resolution for initiating pre-packaged insolvency resolution process.
The EGM addressed a significant resolution regarding the insolvency process, which could have a notable impact on the company and its stakeholders.
The announcement is factual and relates to the proceedings of an EGM, with no inherent positive or negative sentiment.
* Extraordinary General Meeting (EGM) of Vivimed Labs Limited was held on Wednesday, December 10, 2025, at 3:00 P.M. through Video Conferencing (VC) / Other Audio Visual Means (OAVM). * Dr. Manohar Rao Varalwar, Chairman of the Company, chaired the proceedings. * The meeting commenced at 3:00 P.M and concluded at 3:30 P.M * Remote e-voting commenced on Sunday, December 07, 2025 at 9:00 a.m. (IST) and ended on Tuesday, December 09, 2025 at 05:00 p.m. (IST). * The special resolution for application to initiate pre-packaged insolvency resolution process under the Insolvency and Bankruptcy Code, 2016 was put to vote. * The results of voting will be declared on the company's website and sent to the Stock Exchange along with the Scrutinizer's Report.
What to do with a filing like this
Vivimed Labs Limited filed this with the NSE as a statutory disclosure, categorised under shareholder meetings. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Vivimed Labs Limited. Read the original for the full detail.